Global Biosimilar Drug Market Growth 2020-2025

  • receipt Report ID : 61245
  • calendar_today Published On: Nov, 2020
  • file_copy Pages: 132
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this study, over the next five years the Biosimilar Drug market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biosimilar Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar Drug market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Biosimilar Drug, covering the supply chain analysis, impact assessment to the Biosimilar Drug market size growth rate in several scenarios, and the measures to be undertaken by Biosimilar Drug companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Injection

Tablets

Other Types

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Ankylosing Spondylitis

Tumor

Rheumatoid Arthrtis

Cardiovascular

Other Application

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Amgen

Eli Lilly

CP Guojian Pharma

Biotech Pharma

Novartis

...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Biosimilar Drug consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Biosimilar Drug market by identifying its various subsegments.

Focuses on the key global Biosimilar Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Biosimilar Drug with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Biosimilar Drug submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biosimilar Drug Consumption 2015-2025

2.1.2 Biosimilar Drug Consumption CAGR by Region

2.2 Biosimilar Drug Segment by Type

2.2.1 Injection

2.2.2 Tablets

2.2.3 Other Types

2.3 Biosimilar Drug Consumption by Type

2.3.1 Global Biosimilar Drug Consumption Market Share by Type (2015-2020)

2.3.2 Global Biosimilar Drug Revenue and Market Share by Type (2015-2020)

2.3.3 Global Biosimilar Drug Sale Price by Type (2015-2020)

2.4 Biosimilar Drug Segment by Application

2.4.1 Ankylosing Spondylitis

2.4.2 Tumor

2.4.3 Rheumatoid Arthrtis

2.4.4 Cardiovascular

2.4.5 Other Application

2.5 Biosimilar Drug Consumption by Application

2.5.1 Global Biosimilar Drug Consumption Market Share by Type (2015-2020)

2.5.2 Global Biosimilar Drug Value and Market Share by Type (2015-2020)

2.5.3 Global Biosimilar Drug Sale Price by Type (2015-2020)

3 Global Biosimilar Drug by Company

3.1 Global Biosimilar Drug Sales Market Share by Company

3.1.1 Global Biosimilar Drug Sales by Company (2018-2020)

3.1.2 Global Biosimilar Drug Sales Market Share by Company (2018-2020)

3.2 Global Biosimilar Drug Revenue Market Share by Company

3.2.1 Global Biosimilar Drug Revenue by Company (2018-2020)

3.2.2 Global Biosimilar Drug Revenue Market Share by Company (2018-2020)

3.3 Global Biosimilar Drug Sale Price by Company

3.4 Global Biosimilar Drug Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Biosimilar Drug Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Biosimilar Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Biosimilar Drug by Regions

4.1 Biosimilar Drug by Regions

4.2 Americas Biosimilar Drug Consumption Growth

4.3 APAC Biosimilar Drug Consumption Growth

4.4 Europe Biosimilar Drug Consumption Growth

4.5 Middle East & Africa Biosimilar Drug Consumption Growth

5 Americas

5.1 Americas Biosimilar Drug Consumption by Countries

5.1.1 Americas Biosimilar Drug Consumption by Countries (2015-2020)

5.1.2 Americas Biosimilar Drug Value by Countries (2015-2020)

5.2 Americas Biosimilar Drug Consumption by Type

5.3 Americas Biosimilar Drug Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Biosimilar Drug Consumption by Regions

6.1.1 APAC Biosimilar Drug Consumption by Regions (2015-2020)

6.1.2 APAC Biosimilar Drug Value by Regions (2015-2020)

6.2 APAC Biosimilar Drug Consumption by Type

6.3 APAC Biosimilar Drug Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Biosimilar Drug by Countries

7.1.1 Europe Biosimilar Drug Consumption by Countries (2015-2020)

7.1.2 Europe Biosimilar Drug Value by Countries (2015-2020)

7.2 Europe Biosimilar Drug Consumption by Type

7.3 Europe Biosimilar Drug Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Biosimilar Drug by Countries

8.1.1 Middle East & Africa Biosimilar Drug Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Biosimilar Drug Value by Countries (2015-2020)

8.2 Middle East & Africa Biosimilar Drug Consumption by Type

8.3 Middle East & Africa Biosimilar Drug Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Biosimilar Drug Distributors

10.3 Biosimilar Drug Customer

11 Global Biosimilar Drug Market Forecast

11.1 Global Biosimilar Drug Consumption Forecast (2021-2025)

11.2 Global Biosimilar Drug Forecast by Regions

11.2.1 Global Biosimilar Drug Forecast by Regions (2021-2025)

11.2.2 Global Biosimilar Drug Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Biosimilar Drug Forecast by Type

11.8 Global Biosimilar Drug Forecast by Application

12 Key Players Analysis

12.1 Amgen

12.1.1 Company Information

12.1.2 Biosimilar Drug Product Offered

12.1.3 Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Amgen Latest Developments

12.2 Eli Lilly

12.2.1 Company Information

12.2.2 Biosimilar Drug Product Offered

12.2.3 Eli Lilly Biosimilar Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Eli Lilly Latest Developments

12.3 CP Guojian Pharma

12.3.1 Company Information

12.3.2 Biosimilar Drug Product Offered

12.3.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 CP Guojian Pharma Latest Developments

12.4 Biotech Pharma

12.4.1 Company Information

12.4.2 Biosimilar Drug Product Offered

12.4.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Biotech Pharma Latest Developments

12.5 Novartis

12.5.1 Company Information

12.5.2 Biosimilar Drug Product Offered

12.5.3 Novartis Biosimilar Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Novartis Latest Developments

...

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Biosimilar Drug Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Injection

Table 5. Major Players of Tablets

Table 6. Major Players of Other Types

Table 7. Global Consumption Sales by Type (2015-2020)

Table 8. Global Biosimilar Drug Consumption Market Share by Type (2015-2020)

Table 9. Global Biosimilar Drug Revenue by Type (2015-2020) ($ million)

Table 10. Global Biosimilar Drug Value Market Share by Type (2015-2020) ($ Millions)

Table 11. Global Biosimilar Drug Sale Price by Type (2015-2020)

Table 12. Global Consumption Sales by Application (2015-2020)

Table 13. Global Biosimilar Drug Consumption Market Share by Application (2015-2020)

Table 14. Global Biosimilar Drug Value by Application (2015-2020)

Table 15. Global Biosimilar Drug Value Market Share by Application (2015-2020)

Table 16. Global Biosimilar Drug Sale Price by Application (2015-2020)

Table 17. Global Biosimilar Drug Sales by Company (2017-2019) (K Dose)

Table 18. Global Biosimilar Drug Sales Market Share by Company (2017-2019)

Table 19. Global Biosimilar Drug Revenue by Company (2017-2019) ($ Millions)

Table 20. Global Biosimilar Drug Revenue Market Share by Company (2017-2019)

Table 21. Global Biosimilar Drug Sale Price by Company (2017-2019)

Table 22. Global Biosimilar Drug Manufacturing Base Distribution and Sales Area by Manufacturers

Table 23. Players Biosimilar Drug Products Offered

Table 24. Biosimilar Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 25. Global Biosimilar Drug Consumption by Regions 2015-2020 (K Dose)

Table 26. Global Biosimilar Drug Consumption Market Share by Regions 2015-2020

Table 27. Global Biosimilar Drug Value by Regions 2015-2020 ($ Millions)

Table 28. Global Biosimilar Drug Value Market Share by Regions 2015-2020

Table 29. Americas Biosimilar Drug Consumption by Countries (2015-2020) (K Dose)

Table 30. Americas Biosimilar Drug Consumption Market Share by Countries (2015-2020)

Table 31. Americas Biosimilar Drug Value by Countries (2015-2020) ($ Millions)

Table 32. Americas Biosimilar Drug Value Market Share by Countries (2015-2020)

Table 33. Americas Biosimilar Drug Consumption by Type (2015-2020) (K Dose)

Table 34. Americas Biosimilar Drug Consumption Market Share by Type (2015-2020)

Table 35. Americas Biosimilar Drug Consumption by Application (2015-2020) (K Dose)

Table 36. Americas Biosimilar Drug Consumption Market Share by Application (2015-2020)

Table 37. APAC Biosimilar Drug Consumption by Countries (2015-2020) (K Dose)

Table 38. APAC Biosimilar Drug Consumption Market Share by Countries (2015-2020)

Table 39. APAC Biosimilar Drug Value by Regions (2015-2020) ($ Millions)

Table 40. APAC Biosimilar Drug Value Market Share by Regions (2015-2020)

Table 41. APAC Biosimilar Drug Consumption by Type (2015-2020) (K Dose)

Table 42. APAC Biosimilar Drug Consumption Market Share by Type (2015-2020)

Table 43. APAC Biosimilar Drug Consumption by Application (2015-2020) (K Dose)

Table 44. APAC Biosimilar Drug Consumption Market Share by Application (2015-2020)

Table 45. Europe Biosimilar Drug Consumption by Countries (2015-2020) (K Dose)

Table 46. Europe Biosimilar Drug Consumption Market Share by Countries (2015-2020)

Table 47. Europe Biosimilar Drug Value by Countries (2015-2020) ($ Millions)

Table 48. Europe Biosimilar Drug Value Market Share by Countries (2015-2020)

Table 49. Europe Biosimilar Drug Consumption by Type (2015-2020) (K Dose)

Table 50. Europe Biosimilar Drug Consumption Market Share by Type (2015-2020)

Table 51. Europe Biosimilar Drug Consumption by Application (2015-2020) (K Dose)

Table 52. Europe Biosimilar Drug Consumption Market Share by Application (2015-2020)

Table 53. Middle East & Africa Biosimilar Drug Consumption by Countries (2015-2020) (K Dose)

Table 54. Middle East & Africa Biosimilar Drug Consumption Market Share by Countries (2015-2020)

Table 55. Middle East & Africa Biosimilar Drug Value by Countries (2015-2020) ($ Millions)

Table 56. Middle East & Africa Biosimilar Drug Value Market Share by Countries (2015-2020)

Table 57. Middle East & Africa Biosimilar Drug Consumption by Type (2015-2020) (K Dose)

Table 58. Middle East & Africa Biosimilar Drug Consumption Market Share by Type (2015-2020)

Table 59. Middle East & Africa Biosimilar Drug Consumption by Application (2015-2020) (K Dose)

Table 60. Middle East & Africa Biosimilar Drug Consumption Market Share by Application (2015-2020)

Table 61. Biosimilar Drug Distributors List

Table 62. Biosimilar Drug Customer List

Table 63. Global Biosimilar Drug Consumption Forecast by Countries (2021-2025) (K Dose)

Table 64. Global Biosimilar Drug Consumption Market Forecast by Regions

Table 65. Global Biosimilar Drug Value Forecast by Countries (2021-2025) ($ Millions)

Table 66. Global Biosimilar Drug Value Market Share Forecast by Regions

Table 67. Global Biosimilar Drug Consumption Forecast by Type (2021-2025) (K Dose)

Table 68. Global Biosimilar Drug Consumption Market Share Forecast by Type (2021-2025)

Table 69. Global Biosimilar Drug Value Forecast by Type (2021-2025) ($ Millions)

Table 70. Global Biosimilar Drug Value Market Share Forecast by Type (2021-2025)

Table 71. Global Biosimilar Drug Consumption Forecast by Application (2021-2025) (K Dose)

Table 72. Global Biosimilar Drug Consumption Market Share Forecast by Application (2021-2025)

Table 73. Global Biosimilar Drug Value Forecast by Application (2021-2025) ($ Millions)

Table 74. Global Biosimilar Drug Value Market Share Forecast by Application (2021-2025)

Table 75. Amgen Product Offered

Table 76. Amgen Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)

Table 77. Amgen Main Business

Table 78. Amgen Latest Developments

Table 79. Amgen Basic Information, Company Total Revenue (in $ million), Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors

Table 80. Eli Lilly Product Offered

Table 81. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)

Table 82. Eli Lilly Main Business

Table 83. Eli Lilly Latest Developments

Table 84. Eli Lilly Basic Information, Company Total Revenue (in $ million), Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors

Table 85. CP Guojian Pharma Product Offered

Table 86. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)

Table 87. CP Guojian Pharma Main Business

Table 88. CP Guojian Pharma Latest Developments

Table 89. CP Guojian Pharma Basic Information, Company Total Revenue (in $ million), Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors

Table 90. Biotech Pharma Product Offered

Table 91. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)

Table 92. Biotech Pharma Main Business

Table 93. Biotech Pharma Latest Developments

Table 94. Biotech Pharma Basic Information, Company Total Revenue (in $ million), Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Novartis Product Offered

Table 96. Novartis Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)

Table 97. Novartis Main Business

Table 98. Novartis Latest Developments

Table 99. Novartis Basic Information, Company Total Revenue (in $ million), Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Biosimilar Drug

Figure 2. Biosimilar Drug Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Biosimilar Drug Consumption Growth Rate 2015-2025 (K Dose)

Figure 5. Global Biosimilar Drug Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Injection

Figure 7. Product Picture of Tablets

Figure 8. Product Picture of Other Types

Figure 9. Global Biosimilar Drug Consumption Market Share by Type (2015-2020)

Figure 10. Global Biosimilar Drug Value Market Share by Type (2015-2020)

Figure 11. Biosimilar Drug Consumed in Ankylosing Spondylitis

Figure 12. Global Biosimilar Drug Market: Ankylosing Spondylitis (2015-2020) (K Dose)

Figure 13. Global Biosimilar Drug Market: Ankylosing Spondylitis (2015-2020) ($ Millions)

Figure 14. Biosimilar Drug Consumed in Tumor

Figure 15. Global Biosimilar Drug Market: Tumor (2015-2020) (K Dose)

Figure 16. Global Biosimilar Drug Market: Tumor (2015-2020) ($ Millions)

Figure 17. Biosimilar Drug Consumed in Rheumatoid Arthrtis

Figure 18. Global Biosimilar Drug Market: Rheumatoid Arthrtis (2015-2020) (K Dose)

Figure 19. Global Biosimilar Drug Market: Rheumatoid Arthrtis (2015-2020) ($ Millions)

Figure 20. Biosimilar Drug Consumed in Cardiovascular

Figure 21. Global Biosimilar Drug Market: Cardiovascular (2015-2020) (K Dose)

Figure 22. Global Biosimilar Drug Market: Cardiovascular (2015-2020) ($ Millions)

Figure 23. Biosimilar Drug Consumed in Other Application

Figure 24. Global Biosimilar Drug Market: Other Application (2015-2020) (K Dose)

Figure 25. Global Biosimilar Drug Market: Other Application (2015-2020) ($ Millions)

Figure 26. Global Biosimilar Drug Consumption Market Share by Application (2015-2020)

Figure 27. Global Biosimilar Drug Value Market Share by Application (2015-2020)

Figure 28. Global Biosimilar Drug Sales Market Share by Company in 2017

Figure 29. Global Biosimilar Drug Sales Market Share by Company in 2019

Figure 30. Global Biosimilar Drug Revenue Market Share by Company in 2017

Figure 31. Global Biosimilar Drug Revenue Market Share by Company in 2019

Figure 32. Global Biosimilar Drug Sale Price by Company in 2019

Figure 33. Global Biosimilar Drug Consumption Market Share by Regions 2015-2020

Figure 34. Global Biosimilar Drug Value Market Share by Regions 2015-2020

Figure 35. Americas Biosimilar Drug Consumption 2015-2020 (K Dose)

Figure 36. Americas Biosimilar Drug Value 2015-2020 ($ Millions)

Figure 37. APAC Biosimilar Drug Consumption 2015-2020 (K Dose)

Figure 38. APAC Biosimilar Drug Value 2015-2020 ($ Millions)

Figure 39. Europe Biosimilar Drug Consumption 2015-2020 (K Dose)

Figure 40. Europe Biosimilar Drug Value 2015-2020 ($ Millions)

Figure 41. Middle East & Africa Biosimilar Drug Consumption 2015-2020 (K Dose)

Figure 42. Middle East & Africa Biosimilar Drug Value 2015-2020 ($ Millions)

Figure 43. Americas Biosimilar Drug Consumption Market Share by Countries in 2019

Figure 44. Americas Biosimilar Drug Value Market Share by Countries in 2019

Figure 45. Americas Biosimilar Drug Consumption Market Share by Type in 2019

Figure 46. Americas Biosimilar Drug Consumption Market Share by Application in 2019

Figure 47. United States Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 48. United States Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 49. Canada Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 50. Canada Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 51. Mexico Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 52. Mexico Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 53. APAC Biosimilar Drug Consumption Market Share by Countries in 2019

Figure 54. APAC Biosimilar Drug Value Market Share by Regions in 2019

Figure 55. APAC Biosimilar Drug Consumption Market Share by Type in 2019

Figure 56. APAC Biosimilar Drug Consumption Market Share by Application in 2019

Figure 57. China Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 58. China Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 59. Japan Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 60. Japan Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 61. Korea Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 62. Korea Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 63. Southeast Asia Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 64. Southeast Asia Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 65. India Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 66. India Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 67. Australia Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 68. Australia Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 69. Europe Biosimilar Drug Consumption Market Share by Countries in 2019

Figure 70. Europe Biosimilar Drug Value Market Share by Countries in 2019

Figure 71. Europe Biosimilar Drug Consumption Market Share by Type in 2019

Figure 72. Europe Biosimilar Drug Consumption Market Share by Application in 2019

Figure 73. Germany Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 74. Germany Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 75. France Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 76. France Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 77. UK Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 78. UK Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 79. Italy Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 80. Italy Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 81. Russia Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 82. Russia Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 83. Middle East & Africa Biosimilar Drug Consumption Market Share by Countries in 2019

Figure 84. Middle East & Africa Biosimilar Drug Value Market Share by Countries in 2019

Figure 85. Middle East & Africa Biosimilar Drug Consumption Market Share by Type in 2019

Figure 86. Middle East & Africa Biosimilar Drug Consumption Market Share by Application in 2019

Figure 87. Egypt Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 88. Egypt Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 89. South Africa Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 90. South Africa Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 91. Israel Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 92. Israel Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 93. Turkey Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 94. Turkey Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 95. GCC Countries Biosimilar Drug Consumption Growth 2015-2020 (K Dose)

Figure 96. GCC Countries Biosimilar Drug Value Growth 2015-2020 ($ Millions)

Figure 97. Global Biosimilar Drug Consumption Growth Rate Forecast (2021-2025) (K Dose)

Figure 98. Global Biosimilar Drug Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 99. Americas Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 100. Americas Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 101. APAC Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 102. APAC Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 103. Europe Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 104. Europe Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 105. Middle East & Africa Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 106. Middle East & Africa Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 107. United States Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 108. United States Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 109. Canada Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 110. Canada Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 111. Mexico Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 112. Mexico Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 113. Brazil Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 114. Brazil Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 115. China Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 116. China Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 117. Japan Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 118. Japan Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 119. Korea Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 120. Korea Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 121. Southeast Asia Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 122. Southeast Asia Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 123. India Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 124. India Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 125. Australia Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 126. Australia Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 127. Germany Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 128. Germany Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 129. France Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 130. France Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 131. UK Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 132. UK Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 133. Italy Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 134. Italy Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 135. Russia Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 136. Russia Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 137. Spain Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 138. Spain Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 139. Egypt Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 140. Egypt Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 141. South Africa Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 142. South Africa Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 143. Israel Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 144. Israel Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 145. Turkey Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 146. Turkey Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 147. GCC Countries Biosimilar Drug Consumption 2021-2025 (K Dose)

Figure 148. GCC Countries Biosimilar Drug Value 2021-2025 ($ Millions)

Figure 149. Amgen Biosimilar Drug Market Share (2018-2020)

Figure 150. Eli Lilly Biosimilar Drug Market Share (2018-2020)

Figure 151. CP Guojian Pharma Biosimilar Drug Market Share (2018-2020)

Figure 152. Biotech Pharma Biosimilar Drug Market Share (2018-2020)

Figure 153. Novartis Biosimilar Drug Market Share (2018-2020)